Insider buying last 90 days
No open-market insider purchases were filed for JBTM in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
JBT Marel reported third-quarter 2026 results featuring record adjusted EBITDA of $179 million and an 18% margin, with adjusted EPS of $2.19 topping estimates, though revenue of $994 million missed forecasts, prompting shares to fall as much as 6% in reaction. The company raised full-year guidance, projecting adjusted EPS of $8.10 to $8.40 and revenue of $3.95 billion to $4 billion, alongside a new target of a 20% adjusted EBITDA margin by 2028. It also completed a share buyback and authorized an additional $700 million repurchase plan. The Protein Solutions segment posted a 6% revenue rise to $469 million, with its adjusted EBITDA margin climbing to 22.4%, even as management flagged weaker short-cycle demand from consumer packaged goods customers.
JBTM closed at $129.46, up 0.9%, sitting between its 50-day average of $111.67 and 200-day average of $129.83. The stock carries a one-month return of 20.9% but a one-year return of -7.8%. The GekkoIndex reads 36.9, placing it in the Distribution zone, down 13.5 over five days. Price sits 5.6% above Gekko Fair Value of $122.57.
The next earnings date falls on 22 February 2027, 104 days out, beyond a typical 20-day holding window. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows, and there are currently no billionaire or trailblazer holders recorded. Analyst sentiment stands at 4 buy ratings against 1 sell among 5 firms, with a consensus target of $167.38. Seasonally, the next 20 trading days have averaged -0.9% over 5 years, rising in 2 of them, a pattern worth noting given the stock's typical 20-day move of 5.2%.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
JBT Marel scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Averages disagree
Close $125.54 sits between the 50-day ($112.47) and 200-day ($129.23) averages, or the averages disagree.
See the chart48.7, Neutral
Reading 48.7 is in the Neutral zone.
See the GekkoIndex6.9% above
Price is 6.9% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 99 days
Next report Feb 22, 2027, 99 days away — outside a typical 20-trading-day hold.
See earnings+3.0% on average
From this point in the calendar, the next 20 trading days averaged +3% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
JBT Marel closed at $125.54 on Nov 13, 2026, −10.8% over the past year, inside a 52-week range of $102.97 to $170.19.
Use the left and right arrow keys to read daily values.
Put JBTM on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
JBT Marel provides equipment and technology used by food and beverage producers to process, package, and move their products. Its systems handle tasks such as chilling, mixing, cooking, freezing, pasteurizing, weighing, filling, and sealing, alongside end-of-line packaging and material handling. The company also makes automated guided vehicles that move materials through factories, warehouses, and medical facilities, extending its reach beyond food production alone.
Customers include producers of baby food, bakery goods, confectionery, citrus and other fruit and nut products, juice, pet food, pharmaceuticals, plant-based beverages and proteins, poultry, meat, seafood, and ready meals. It also works with non-food industries such as automotive, building materials, tissue and paper, packaging, and hospitals. Products and services reach customers through a direct sales team along with independent distributors, sales representatives, and technical service staff, reflecting a business built on both equipment sales and ongoing service support.
The company operates across North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. It was formerly called John Bean Technologies Corporation before taking the name JBT Marel Corporation in January 2025. Shares of JBT Marel are listed on the NYSE under the ticker JBTM.
JBT Marel’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48.7, in the Neutral zone, up 12.2 points over five sessions.
Up 12.2 points over five sessions, from the Distribution zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 38 | +0.4% | +4.4% | ||
| Accumulation | 221 | +0.5% | +0.2% | ||
| Neutral (current zone) | 396 | +0.4% | +0.4% | ||
| Distribution | 44 | −1.8% | +3.1% | ||
| Selling | 3 | Too few readings yet | |||
Average JBTM share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
JBT Marel trades 6.9% above Gekko Fair Value of $117.41, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what JBT Marel shares are worth, recalculated every trading day.
$117.41
Gekko Fair Value, Nov 14, 2026
6.9% Overvalued
At the end of Aug 2026 the price was 9.3% below the estimate.
No open-market insider purchases were filed for JBT Marel, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for JBTM in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in JBTM were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
JBT Marel has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold JBTM.
JBT Marel reports on Feb 22, 2027 (99 days away), and beat the EPS estimate in 4 of its last 8 reports.
Feb 22, 2027
99 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 28, 2026 | $0.00 est $1.62 | — | −9.5% |
| Feb 24, 2026 | $1.98 est $1.90 | $1.01B est $993.4M | −4.0% |
| Nov 3, 2025 | $1.94 est $1.51 | $1.00B est $990.6M | +9.8% |
| Aug 7, 2025 | $0.07 est $1.27 | $934.8M est $924.2M | −0.3% |
| May 5, 2025 | $0.97 est $0.82 | $854.1M est $885.1M | −2.1% |
| Feb 24, 2025 | $1.70 est $1.82 | $467.6M est $489.1M | +13.7% |
| Oct 22, 2024 | $1.50 est $1.41 | $453.8M est $442.2M | +14.8% |
| Jul 30, 2024 | $1.05 est $1.22 | $402.3M est $432.6M | +1.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for JBT Marel is $160.12, +27.5% from the last close, from 6 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 6 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | Jefferies | $142 | +13.1% |
| Nov 5 | Bank of America Securities | — | — |
| Nov 4 | Barclays | $150 | +19.5% |
| Nov 4 | KeyBanc | $150 | +19.5% |
| Oct 23 | Bank of America Securities | $118 | −6.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, JBT Marel averaged +3.0% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.2% | 2 of 5 |
| Next 10 trading days | −1.0% | 2 of 5 |
| Next 15 trading days | −0.8% | 2 of 5 |
| Next 20 trading days | +3.0% | 3 of 5 |
| Next 30 trading days | +0.4% | 2 of 5 |
For scale, JBTM’s typical 20-trading-day move in either direction is about 5.2%.
JBT Marel’s market cap is $6.41B, with a P/E ratio of 33.5 and revenue of $3.92B over the last twelve months.
Coverage of JBT Marel this week reads neutral: 1 positive, 3 neutral and 0 negative headlines.
JBT Marel’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| AMATApplied Materials | Accumulation | 27.3% below |
| LRCXLam Research | Accumulation | 14.7% below |
| PHParker-Hannifin | Neutral | 4.5% above |
| TTTrane Technologies | Accumulation | 6.8% above |
| JCIJohnson Controls International | Accumulation | 6.6% above |
| CARRCarrier Global | Neutral | 0.0% above |
A peer links to its own page where one exists.
JBT Marel’s market cap is $6.41B at the Nov 13, 2026 close of $125.54, with 51.08M shares outstanding. The shares trade on a P/E ratio of 33.5.
The consensus analyst 12-month price target for JBT Marel is $160.12, +27.5% from the last close. Of the 6 firms that rated the stock in the last 90 days, 4 rate it a buy, 1 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate JBT Marel is overvalued: the Nov 13, 2026 close of $125.54 is 6.9% above Gekko Fair Value of $117.41. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
JBT Marel is expected to report on Feb 22, 2027 (99 days away). Analysts expect earnings of $2.46 per share on revenue of $1.06B. JBT Marel beat the earnings estimate in 4 of its last 8 reports, moving 6.9% on average across the report.
JBT Marel’s 52-week high is $170.19 and its 52-week low is $102.97; it closed at $125.54 on Nov 13, 2026, −10.8% over the past year. Over the last five years the shares peaked at $177.56 on Nov 22, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (earnings risk and seasonality), 2 as mixed (trend and gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.